Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up
AB

ABBV

Market Closed

AbbVie Inc.

NYSEHealthcareDrug Manufacturers - General
US
55.00K employees
CEO: Robert A. Michael
Founded: 2013
$251.52
+$0.00(+NaN%)
Market Cap
444.38B
Beta
0.31
52W Range
N/A
Dividend Yield
2.68%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: AbbVie's current price exceeds the PERT-weighted fair value by 25%, indicating potential overvaluation with high downside risk (83.3% scenarios below current price). Financial health reveals low profitability and growth amid high leverage, increasing volatility (40.19% coefficient of variation). Analyst targets and trading range suggest some optimism, but overall valuation signals elevated investment risk.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore ABBV

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ABBV in the Healthcare

Mega Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms